1. Home
  2. CISO vs MRNS Comparison

CISO vs MRNS Comparison

Compare CISO & MRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CISO
  • MRNS
  • Stock Information
  • Founded
  • CISO 2015
  • MRNS 2003
  • Country
  • CISO United States
  • MRNS United States
  • Employees
  • CISO N/A
  • MRNS N/A
  • Industry
  • CISO Computer Software: Prepackaged Software
  • MRNS Biotechnology: Pharmaceutical Preparations
  • Sector
  • CISO Technology
  • MRNS Health Care
  • Exchange
  • CISO Nasdaq
  • MRNS Nasdaq
  • Market Cap
  • CISO 32.7M
  • MRNS 29.9M
  • IPO Year
  • CISO N/A
  • MRNS 2014
  • Fundamental
  • Price
  • CISO $1.26
  • MRNS N/A
  • Analyst Decision
  • CISO
  • MRNS Buy
  • Analyst Count
  • CISO 0
  • MRNS 12
  • Target Price
  • CISO N/A
  • MRNS $4.28
  • AVG Volume (30 Days)
  • CISO 112.2K
  • MRNS 1.2M
  • Earning Date
  • CISO 11-18-2024
  • MRNS 03-04-2025
  • Dividend Yield
  • CISO N/A
  • MRNS N/A
  • EPS Growth
  • CISO N/A
  • MRNS N/A
  • EPS
  • CISO N/A
  • MRNS N/A
  • Revenue
  • CISO $54,633,909.00
  • MRNS $31,466,000.00
  • Revenue This Year
  • CISO $78.76
  • MRNS $14.97
  • Revenue Next Year
  • CISO N/A
  • MRNS $57.65
  • P/E Ratio
  • CISO N/A
  • MRNS N/A
  • Revenue Growth
  • CISO 34.87
  • MRNS 1.63
  • 52 Week Low
  • CISO $0.26
  • MRNS $0.22
  • 52 Week High
  • CISO $3.84
  • MRNS $10.50
  • Technical
  • Relative Strength Index (RSI)
  • CISO 54.18
  • MRNS 8.78
  • Support Level
  • CISO $0.96
  • MRNS $0.54
  • Resistance Level
  • CISO $1.03
  • MRNS $0.55
  • Average True Range (ATR)
  • CISO 0.09
  • MRNS 0.00
  • MACD
  • CISO 0.05
  • MRNS -0.07
  • Stochastic Oscillator
  • CISO 80.22
  • MRNS 0.00

About CISO CISO Global Inc.

CISO Global Inc provides cybersecurity services. The services are used to protect client's data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in U.S., Chile and All other countries. The maximum revenue is generated from U.S.

About MRNS Marinus Pharmaceuticals Inc.

Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.

Share on Social Networks: